Company / Revenue
Harvard Apparatus Regenerative Technology, Inc. Revenue History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$704.0K
FY2025
5-year range
$0 / $704.0K
FY2021-FY2025
Trend
+63.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 3 consecutive years, from $0 in FY2021 to $704,000 in FY2025.
Based on SEC 10-K filings.
$704,000 in FY2025 with a 10-year CAGR of +19.6%.
Improved from $103,000 to $704,000 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +19.6%
Key checks
Key Insights
- In FY2025, revenue increased 63.7% year-over-year.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $704.0K | +63.7% |
| FY2024 | $430.0K | +317.5% |
| FY2023 | $103.0K | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $82.0K | -30.5% |
| FY2015 | $118.0K | +26.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026